Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fate Therapeutics (FATE) Restructuring Costs (2023)

Historic Restructuring Costs for Fate Therapeutics (FATE) over the last 1 years, with Q1 2023 value amounting to $2.0 million.

  • Fate Therapeutics' Restructuring Costs changed N/A to $2.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2023, which is N/A changed from last year.
  • Per Fate Therapeutics' latest filing, its Restructuring Costs stood at $2.0 million for Q1 2023.
  • Fate Therapeutics' Restructuring Costs' 5-year high stood at $2.0 million during Q1 2023, with a 5-year trough of $2.0 million in Q1 2023.